MPGES1 expression has been associated to CRC incidence and prognosis (Seo et al., 2009; Sasaki et al., 2012) and has been proposed to cooperate with COX-2 to enhance tumor growth (Kamei et al., 2003). The gene discussed is PTGS2; the disease is colorectal carcinoma.